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Among the basal ganglia-thalamocortical circuits, the putamen plays a critical role in
the “motor” circuits that control voluntary movements and motor learning. The human
neostriatum comprises two functional subdivisions known as the striosome (patch)
and matrix compartments. Accumulating evidence suggests that compartment-specific
dysregulations of dopamine activity might be involved in the disease-specific pathology
and symptoms of human striatal diseases including movement disorders. This study was
undertaken to examine whether or how striatal dopaminergic innervations are organized
into the compartmentalized architecture found in the putamen of adult human brains.
For this purpose, we used a highly sensitive immunohistochemistry (IHC) technique
to identify tyrosine hydroxylase (TH; EC 1.14.16.2), a marker for striatal dopaminergic
axons and terminals, in formalin-fixed paraffin-embedded (FFPE) tissues obtained
from autopsied human brains. Herein, we report that discrete compartmentalization
of TH-labeled innervations occurs in the putamen, as in the caudate nucleus (CN),
with a higher density of TH labeling in the matrix compared to the striosomes. Our
results provide anatomical evidence to support the hypothesis that compartment-
specific dysfunction of the striosome-matrix dopaminergic systems might contribute to
the genesis of movement disorders.
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INTRODUCTION
The human neostriatum comprising the caudate nucleus (CN) and putamen is the primary input
region of the basal ganglia, a group of subcortical nuclei that control a wide range of sensorimotor,
cognitive and emotional functions (for review see, Graybiel, 2008; Amemori et al., 2011). It has
so far been known that the basal ganglia are organized into several structurally and functionally
distinct neural circuits that link the cortex, basal ganglia, and thalamus, with each circuit focused
on a different frontal cortex territory (Alexander et al., 1986, 1990). Among these basal ganglia-
thalamocortical circuits, the putamen participates in the ‘‘motor’’ circuits and is thereby important
to basal ganglia motor control and movement disorders (Albin et al., 1989; DeLong, 1990).
Parkinson’s disease (PD) results from a striatal dopamine deficiency due to the neurodegenerative
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loss of dopamine-producing cells in the substantia nigra pars
compacta (SNc; Hirsch et al., 1988). Kish et al. (1988) showed
that the depletion of dopamine in patients with PD was most
remarkable in the putamen, particularly in its caudal portions.
Goto et al. (1989a, 1996) also documented that in parkinsonian
patients, a pathological lesion was found specifically in the
nigrostriatal loop that forms a link with the putamen.
The mammalian neostriatum is composed of two functional
subdivisions known as the striosome (patch) and matrix
compartments, which are developmentally, anatomically, and
biochemically distinct (Graybiel and Ragsdale, 1978; Bolam
et al., 1988; Graybiel, 1990; Gerfen, 1992). The striosome and
matrix compartments make up about 15% and 85% of the
volume of the striatum, respectively, in mammalian brains
(Johnston et al., 1990). Although single dopaminergic afferent
axons can terminate in both the compartments (Matsuda
et al., 2009), the striosomes and matrix tend to receive
dopaminergic afferents from distinct groups of SNc neurons.
The striosomal cells are preferentially innervated by a group
of dopamine-producing cells in the ventral tier of the SNc
(Gerfen et al., 1987; Jimenez-Castellanos and Graybiel, 1987;
Langer and Graybiel, 1989; Prensa and Parent, 2001), while
the matrix cells preferentially receive the afferents arising from
dopaminergic cells in the dorsal tier of the SNc, the ventral
tegmental area and the retrorubral area (Gerfen et al., 1987;
Jimenez-Castellanos and Graybiel, 1987; Prensa and Parent,
2001).
Accumulating evidence suggests that striosome-matrix
dopaminergic systems exert a critical role in basal ganglia-
thalamocortical circuits (Graybiel, 2008; Amemori et al.,
2011). Interestingly, imbalanced dopamine activity between
the striosome and matrix compartments has been suggested
to underlie the genesis of pathological lesions and clinical
symptoms that occur in multiple movement disorders
(Graybiel, 2008; Goto et al., 2010; Crittenden and Graybiel,
2011), such as the L-DOPA-induced dyskinesia associated
with PD (Graybiel et al., 2000). However, despite previous
immunohistochemical studies using frozen sections (Ferrante
and Kowall, 1987; Graybiel et al., 1987; Holt et al., 1997; Ciliax
et al., 1999; Prensa et al., 1999, 2000), it remains undetermined
whether or how striatal dopaminergic innervations might be
organized into a discrete striosome-matrix axis in the human
putamen.
To address this issue, we employed a highly-sensitive
immunohistochemistry (IHC) method (Goto et al., 2015) to
identify tyrosine hydroxylase (TH; EC 1.14.16.2) in formalin-
fixed paraffin-embedded (FFPE) striatal tissues from autopsied
human brains. TH serves as a reliable marker for visualizing
dopaminergic axons and terminals in the striatum (Moss
and Bolam, 2008). Here, we show that as in the CN,
discrete compartmentalization of TH immunoreactivity occurs
in the putamen, with a higher density of TH labeling in
the matrix compartment relative to the striosomes. Our
results provide anatomical evidence to support the hypothesis
that compartment-specific dysfunction of the striosome-matrix
dopaminergic systems might contribute to the genesis of human
movement disorders.
MATERIALS AND METHODS
Western Blot Analysis on Mouse Brains
All procedural protocols that involve mouse experiments were
approved by the Ethical Review Committee of the Tokushima
University. We used male C57BL/6 mice (Nihon SLC Co.,
Shizuoka, Japan; n = 3) aged 8–10 weeks. Western blot
analysis was performed with a rabbit polyclonal antibody
against TH (Sato et al., 2008), according to the method that
we previously ported (Morigaki and Goto, 2015). Blots were
developed by chemiluminescent autoradiography (ECL plus kit;
GE Healthcare, Buckingham, UK).
IHC for TH in Mouse Brains
After receiving an intraperitoneal injection of a lethal dose of
pentobarbital (Sigma-Aldrich, St. Louis, MO, USA), mice (n = 5)
were transcardially perfused with cold PBS, and followed by cold
4% paraformaldehyde in 0.1M phosphate buffer (pH 7.2). Frozen
sections with 16-µm thickness were processed for the IHC with
the tyramide signal amplification (TSA) technique in a free-
floating manner, as in our previous reports (Okita et al., 2012;
Morigaki and Goto, 2015). Briefly, rabbit polyclonal antibody
against TH (1:100,000) was used as a primary antibody. To detect
the bound antibody, we used the Histofine Simple Stain Kit
(Nichirei, Tokyo, Japan) and the TSA Plus Cyanine 3 System
(Perkin Elmer, Shelton, CT, USA).
Human Brain Tissue Preparation for IHC
All procedural protocols that involve autopsied human brains
were approved by the Ethical Review Committee of the
Tokushima University. FFPE striatal sections with 4-µm-
thickness were prepared from the autopsied brain tissues of
neurologically-normal patients (n = 5; mean age ± SEM, 59 ± 8
years), as we previously described (Morigaki and Goto, 2015).
After deparaffinization and rehydration, all sections were treated
with 1% H2O2 in water for 5 min. For the antigen retrieval,
they were then immersed in 0.01 M sodium citrate buffer (pH
6.0) and placed in a 700-W microwave for 15 min. Endogenous
binding sites for avidin and biotin were blocked by using the
Avidin/Biotin Blocking Kit (Vector, Burlingame, CA, USA). The
sections were then immersed in 3% BSA-PBS for 60 min and they
were processed for the IHC protocols described below.
IHC with 3,3
′
-Diaminobenzidine (DAB) in
Human Brain Tissue
The sections were incubated for 18 h in 3% BSA-PBS containing
a rabbit polyclonal antibody against TH (1:200,000; Sato
et al., 2008) or [Met]-enkephalin (MEnk; 1:500,000; Millipore,
St. Louis, MO, USA; Goto et al., 2015). They were then processed
for a hybrid IHC protocol that implements aspects of both
the polymer-staining and avidin-biotin-complex (ABC) methods
combining with the biotin-TSA system, as we previously reported
(Goto et al., 2015). Briefly, the sections were incubated for 30min
in the polymer-staining solution (Histofine Simple Stain Kit;
Nichirei). After several rinses in PBS, they were incubated for
30 min with biotinyl TSA solution prepared from a TSA Biotin
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FIGURE 1 | Identification of tyrosine hydroxylase (TH) in the mouse striatum. (A) Western blot assay. Crude homogenates of protein (10 µg) from the mouse
striatum were separated on a 10% gel by SDS-PAGE and then immunoblotted using anti-TH antibody. An immunostained protein band (arrow) was selectively
detected, with an approximate molecular mass corresponding to the predicted size of native TH protein. PS, protein staining; IB, immunoblot. (B) Photomicrograph
of a striatal section stained for TH. TH immunoreactivity appears to be homogeneously distributed throughout the dorsal striatum (DS). (C) Photomicrograph of the
striatal area stained for TH. Numerous tiny TH-positive dots were found in the striatum. (D) Photomicrograph of the DS processed using the immunostaining protocol
without anti-TH antibody. (E) Photomicrograph of the midbrain stained for TH. Arrows indicate the substantia nigra pars compacta (SNc). (F) Photomicrograph of
nigral dopaminergic cells positive for TH. Abbreviations: DS, dorsal striatum; NA, nucleus accumbens; OT, olfactory tubercle. Scale bars: (B) 500 µm, (C,D) 20 µm,
(E) 1 mm, (F) 50 µm.
System kit (Perkin Elmer) with 1× Plus Amplification Diluent
(Perkin Elmer). After several rinses in PBS, they were incubated
for 30min with the ABC reagent prepared from aVectastain Elite
ABC kit (Vector). After several rinses in PBS, the sections were
immersed for 10 min in 0.05 M Tris-HCl (pH 7.4) containing
0.05% diaminobenzidine (DAB; Merck, Darmstadt, Germany)
and 0.01% H2O2. After dehydration, the sections stained with
DAB were cover-slipped with Malinol (Muto Pure Chemicals,
Tokyo, Japan).
IHC with Fluorescents in Human Brain
Tissue
The sections were first incubated for 18 h in 3% BSA-PBS
containing rabbit polyclonal antibody against TH (1:100,000;
Sato et al., 2008). After several rinses in PBS, the bound
antibodies were visualized by using the Histofine Simple Stain
Kit (Nichirei) and the TSA Plus Cyanine3 System (Perkin Elmer).
The sections were then treated for 30 min in 0.1 M glycine-HCl
(pH 2.2) to remove the first primary antibodies. After several
rinses in PBS, they were incubated for 18 h in 3% BSA-PBS
containing rabbit polyclonal antibody against MEnk (1:200,000;
Millipore) or dopamine and cAMP-regulated phosphoprotein of
32 kDa (DARPP-32; 1:20,000; Cell Signaling, Denver, MA, USA).
The bound antibodies were visualized by using the Histofine
Simple Stain Kit (Nichirei) and the TSA Plus Fluorescein System
(Perkin Elmer; Morigaki and Goto, 2015).
Digital Imaging and Morphometric Analysis
To capture macroscopic images, we used an Epson ES-2200
color image scanner (SEIKO EPSON Co., Nagano, Japan).
Microscopic images were captured using an Olympus
BX51 microscope (Olympus, Tokyo, Japan) equipped with
a digital camera DP40 (Olympus). By means of Adobe
Photoshop CS4, all captured images were digitally processed
with minimal adjustments to contrast, brightness, and color
balance.
Morphometric analysis was performed using an image-
analyzer (MetaMorph, Molecular Device, Tokyo, Japan). We
measured the optical density of TH-immunoreactive products
in the striosome and matrix subfields represented by gray
levels on non-colored digital images at low magnification, as
previously reported (Sato et al., 2008; Morigaki and Goto,
2015). For each human striatum (n = 5), we measured five
striatal subfields of the CN, rostral putamen, and caudal
putamen.
We also measured the striosomal areas delineated by faint
TH staining or dense MEnk staining in the CN (n = 5), rostral
putamen (n = 5), and caudal putamen (n = 5) from each
autopsied brain (n = 5). The mean values were used to quantify
the percentage of the striatal area occupied by the striosome
compartment.
To determine the cell density, we counted the numbers of
neurons positive for TH or DARPP-32 in a 1 mm × 1 mm field
in the human neostriatum, as described in our previous report
(Goto et al., 2013). We examined five fields selected randomly in
each of the CN and putamen from each patient (n = 5).
Statistical Analysis
All quantitative data are presented as the mean ± SEM.
Two-group comparisons were made using the Student’s t-test
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FIGURE 2 | Non-homogeneous distribution of TH in the human neostriatum. (A,B) Bright-field (A) and dark-field (B) images taken from a frontal section of the
striatum stained with diaminobenzidine (DAB) for TH. (C,D) Bright-field (C) and dark-field (D) images taken from a frontal section of the striatum stained with DAB for
[Met]-enkephalin (MEnk), a marker for striosomes (patches). Note that they are contiguous to those shown in (A,B). Abbreviations: CN, caudate nucleus; Put,
putamen; NA, nucleus accumbens. Scale bars: 5 mm.
(two-tailed, paired). Significant differences were considered as
P < 0.05.
RESULTS
Immunochemical Detection of TH in
Mouse Brains
To determine the monospecificity of the anti-TH antibody
used here, we first performed a western-blot analysis of
the mouse brains. Immunoblots (IBs) of mouse striatal
extracts showed a single protein band with an approximate
molecular mass that corresponds to the predicted size of
native TH protein (Figure 1A). The staining specificity was
also assessed on frozen striatal sections from adult mouse
brains with or without anti-TH antibody (Figures 1B–D).
In the presence of the antibody, specific TH staining was
detected in the striatum (Figure 1B), where numerous
TH-positive puncta were densely found (Figure 1C). In
agreement with our previous report (Sato et al., 2008), the
distribution of TH labeling was diffuse and homogeneous
throughout the striatum in adult mice. By contrast, TH
immunoreactivity was not seen in striatal sections processed
for the IHC protocol in the absence of the antibody
(Figure 1D). In addition, strong TH labeling was also seen
in the midbrain (Figure 1E), where SNc neurons exhibited
intense TH immunoreactivity in their cell bodies and neurites
(Figure 1F).
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FIGURE 3 | Mosaic pattern of TH-immunostaining in the rostral putamen of the human brains. (A–D) Photomicrographs of the dark-field images taken from
the dorsal (A,B) and ventral portions (C,D) of the rostral putamen stained with DAB for TH. Asterisks indicate examples of striatal subfields with sparse TH labeling.
(E,F) Graded color-converted representations of dark-field (E) and bright-field (F) images of the striatal area stained with DAB for TH, which is shown in (A). A
standard pseudocolor scale from blue (lowest level) through green, yellow, red, and white (highest level) was used. Asterisks indicate examples of corresponding
zones poor in TH-labeling. Scale bars: 2 mm.
Putaminal Mosaic Pattern Visualized by
TH-Immunostaining with DAB in Human
Brains
A highly-sensitive IHC technique (Goto et al., 2015) allowed us
to detect TH immunoreactivity in FFPE human autopsy tissue.
Specific TH labeling was identified in the neostriatum composed
of the CN and putamen. No TH labeling was detected in striatal
sections processed for the IHC protocol without the anti-TH
antibody. Bright-field (Figure 2A) and dark-field (Figure 2B)
images are shown of a striatal section stained with DAB for
TH. These macroscopic images reveal that in both the CN and
putamen, TH labeling is distributed in a non-homogeneous
pattern of low- and high-imunoreactive zones. Notably, patches
of low TH immunoreactivity were evident in the putamen, as in
the CN.
On FFPE striatal tissue obtained from autopsied human
brains, MEnk is one of the most reliable IHC markers for
visualizing striatal compartments with higher density of MEnk
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FIGURE 4 | Compartmental distribution of TH immunoreactivity in the caudal putamen of the human brains. (A–D) Serial-section analysis of dark-field
images of the lenticular nucleus (A,B) and caudal putamen (C,D) stained with DAB for TH (A,C) and MEnk (B,D). Asterisks indicate examples of corresponding
striosomes. (E) Photomicrograph at the border between the striosome and matrix in a putaminal area stained with DAB for TH. (F,G) Photomicrographs of the matrix
(F) and striosome (G) in the putamen stained with DAB for TH. Note that the matrix area revealed a greater density of TH-positive fibers and puncta, compared with
the striosomal area. Abbreviations: CN, caudate nucleus; Put, putamen; GPe, globus pallidus externa; GPi; globus pallidus interna; IC, internal capsule. Scale bars:
(A,B) 5 mm, (C,D) 2 mm, (E) 500 µm, (F,G) 100 µm.
FIGURE 5 | Densitometric analysis of the human striatum stained for
TH. Measurements of the optical density of TH-immunoreactive DAB products
were performed in the striosome (S) and matrix (M) compartments of the CN,
rostral putamen and caudal putamen. Data represent means ± SEM (bars),
n = 25. ∗∗ indicates P = 0.01, M vs. S; ∗ indicates P = 0.05, M vs. S.
labeling in the striosomes than in the matrix (Goto et al.,
2013, 2015). Bright-field and dark-field images of a striatal
section stained with DAB for MEnk are shown in Figures 2C,D,
respectively. Contiguous sections stained for TH (Figures 2A,B)
and MEnk (Figures 2C,D) show a correspondence between
zones of low TH labeling and those of heightened MEnk labeling
in both the CN and putamen.
On dark-field microscopic images with low magnification,
compartmental patterning of TH labeling was found in the
rostral putamen (Figures 3A–D). A mosaic pattern of low-
and high-immunoreactive zones that varied in their shapes and
sizes was seen in both the dorsal (Figures 3A,B) and ventral
(Figures 3C,D) portions of the rostral putamen. This was also
evident in the graded color-converted images of dark-field
(Figure 3E) and bright-field (Figure 3F) images of the putaminal
area shown in Figure 3A.
Dark-field macroscopic images of contiguous sections of
the lenticular nucleus stained with DAB for TH and MEnk
are shown in Figures 4A,B, respectively. They represent
the complementary distribution of TH and MEnk in the
caudal portion of the putamen. Microscopic images with
low magnification (Figures 4C,D) also show a striking
correspondence between the TH-poor zones and the MEnk-
rich striosomes. A photomicrograph of the border between the
striosome and matrix areas (Figure 4E) shows less dense TH
immunoreactivity in the striosome compared to the matrix.
Higher-magnification images also demonstrate that the matrix
area contains a greater density of TH-positive fibers and puncta
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FIGURE 6 | Neostriatal mosaic visualized by TH-immunostaining with Cyanine 3 in human brains. (A) A photomontage of a striatal section stained for TH.
(B,C) Photomicrographs of the CN (B) and putamen (C) in the striatum stained for TH. (D,E) Photomicrographs of areas stained for TH in the matrix (D) and
striosome (E) of the putamen. Abbreviations: CN, caudate nucleus; Put, putamen; NA, nucleus accumbens. Scale bars: (A) 5 mm, (B,C) 2 mm, (D,E) 50 µm.
FIGURE 7 | Pattern of localization of TH in the striosome-matrix domains of the human neostriatum. (A–D) Photomicrographs of the CN (A,B) and
putamen (C,D) double-stained for TH (A,C) and MEnk (B,D). Corresponding striosomes are indicated by asterisks. (E–G) Photomicrographs of an area of the
putamen double-stained for TH (E) and MEnk (F), with a merged image (G). Corresponding striosomes are indicated by asterisks. Note that the margins of the
TH-poor zones correspond to the outer margins of the striosomes enriched in MEnk. (H) Depicted are the patterns of localization of MEnk (upper) or TH (lower) in
the striosome-matrix system. The striosome consists of annular and core zones. Higher densities of TH or MEnk-immunoreactive products are indicated by higher
gray-scale levels. Scale bars: (A–D) 500 µm, (E–G) 250 µm.
(Figure 4F), compared with the striosomal area (Figure 4G). To
confirm this visual impression, the optical density was measured
on areas of the striosome and matrix in the CN, rostral putamen,
and caudal putamen (Figure 5). The results showed that in all the
striatal areas examined, the density of TH-labeling in the matrix
was significantly higher than that in the striosomes.
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FIGURE 8 | Morphometric analysis of the percentage of the striatum occupied by the striosome compartment in the human neostriatum.
(A–F) Gray-scale-converted microscopic images of striatal areas stained with fluorescence for TH (A–C) and MEnk (D–F) in the CN (A,D), rostral putamen (B,E), and
caudal putamen (C,F). Asterisks indicate examples of striosomes. Scale bars: 1 mm. (G) Measurements of the percentage of the striatum occupied by the striosome
compartment identified by TH-immunostaining in the CN, rostral putamen, and caudal putamen. Data represent means ± SEM (bars), n = 25. ∗∗ indicates P < 0.01
vs. CN; N.S. (not significant) indicates P > 0.05, Rostral Putamen vs. Caudal Putamen. (H) Measurements of the percentage of the striatum occupied by the
striosome compartment identified by MEnk-immunostaining in the CN, rostral putamen, and caudal putamen. Data represent means ± SEM (bars), n = 25.
∗∗ indicates P < 0.01 vs. CN; N.S. (not significant) indicates P > 0.05, Rostral Putamen vs. Caudal Putamen.
Putaminal Mosaic Visualized by
TH-Immunofluorescence in Human Brains
Specific immunoreactivity for TH in the human neostriatum was
also identified by our IHC protocols using fluorescence. In a
photomontage of the striatum stained with Cyanine 3 for TH
(Figure 6A), mosaic patterns were clearly seen in both the CN
and putamen, as shown in Figure 2. Microscopic images with low
magnification also revealed the compartmentalized distribution
of TH labeling in the CN (Figure 6B) and putamen (Figure 6C).
At higher-magnification, abundant TH-immunoreactive fibers
and puncta were seen in the matrix (Figure 6D), but less so in
the striosomes (Figure 6E).
Double immunofluorescence staining also revealed that TH
immunoreactivity was sparse in the MEnk-enriched striosomes
in the CN (Figures 7A,B) and putamen (Figures 7C,D). At
higher-magnification, the margins of the TH-poor zones closely
corresponded with the outer margins of the MEnk-rich zones
(Figures 7E–G). Within the striosomes, there exist specialized
zones rimming the striosomes, which are referred to as ‘‘annular’’
or ‘‘striocapsular’’ zones (Graybiel et al., 1981; Gerfen et al.,
1985; Jakab et al., 1996; Holt et al., 1997; Brimblecombe and
Cragg, 2015). These express higher levels of MEnk than the core
(center) zones, as depicted in Figure 7H. Based on the findings
shown here, it is likely that TH immunoreactivity is diffusely
distributed within the striosomes, with no apparent difference
in the TH-staining intensity between the annular and core zones
(Figure 7H).
Representative gray-scale images of the striatal areas stained
for TH (Figures 8A–C) and MEnk (Figures 8D–F) are shown
for the CN (Figures 8A,D), rostral putamen (Figures 8B,E),
and caudal putamen (Figures 8C,F). These images (also
see, Figures 2, 6) reveal an apparent difference in the
striosome-to-matrix ratio among striatal areas. To confirm this
visual impression, we carried out a morphometric analysis
of the striatal sections. In the striatum stained for TH
(Figure 8G), the percentage of the striatum occupied by
the striosome compartment in the CN (18.2% ± 3.2%)
was significantly different (P < 0.05) from that in both
the rostral putamen (29.8% ± 6.7%) and caudal putamen
(28.1% ± 5.2%). In the striatum stained for MEnk (Figure 8H),
the percentage of the striatum occupied by the striosome
compartment in the CN (14.0% ± 2.1%) was significantly
different (P < 0.05) from that in both the rostral putamen
(29.2% ± 6.4%) and caudal putamen (28.1% ± 5.1%). Thus, the
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FIGURE 9 | Scarcity of TH-positive interneurons in the human neostriatum. (A–D) Photomicrographs of the CN (A,C) and putamen (B,D) stained for TH
(A,B) and DARPP-32 (C,D). The TH-positive cells are indicated by dashed open circles (A,B). Higher-magnification images of the TH-positive cells are also shown in
the insets in (A,B). Scale bars: (A–D) 200 µm, (insets in A and B) 20 µm. (E,F) Cell density measurements of striatal cells positive for TH or dopamine and
cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) in the CN (E) and putamen (F). Values are means ± SEM (bars), n = 25.
striosome-to-matrix ratio of the putamen was 1.5∼2.0 times that
of the CN.
Sparse Distribution of TH-Expressing
Interneurons in the Human Neostriatum
It is known that the mammalian striatum contains a
distinguished subgroup of GABAergic interneurons that
express TH (for review see, Silberberg and Bolam, 2015).
In this study, we also identified the TH-positive cells
in both the CN and putamen (Figure 9). However, cell
density analysis (Figures 9E,F) revealed that the TH
cells were only sparsely distributed in the CN (1.8 ± 1.1
cells/mm2) and putamen (1.6 ± 1.0 cells/mm2), while
striatal cells positive for DARPP-32, a marker for medium
spiny neurons (Okita et al., 2012), were abundantly
found in the CN (201 ± 22 cells/mm2) and putamen
(192± 31 cells/mm2).
DISCUSSION
In this study, we showed an immunohistochemical evidence
that TH is compartmentally distributed in both the CN and
putamen in FFPE human autopsy brains. By means of the serial
section analysis and the double fluorescent labeling technique,
the present study indicates that TH is enriched in the matrix
compartment relative to the striosomes at the striatal levels
from the rostral to the caudal throughout. We suggest that
in the entire neostriatum, TH immunoreactivity forms the
distinct striosome-matrix configurations in the same manner.
This notion may contradict the previous report indicating that
in the human striatum, striosomes are largely devoid of TH at
rostral striatal levels while the inverse is found caudally (Prensa
et al., 1999).
TH is highly concentrated in the neostriatum, where nearly
all of it is expressed in axons of the dopaminergic nigrostriatal
afferents. However, it has so far been known that in the
mammalian striatum, there exists a subset of GABAergic
interneurons that express TH (Silberberg and Bolam, 2015),
although their roles in striatal dopamine systems have not yet
been determined (Xenias et al., 2015). This means that striatal
TH labeling is composed of not only the TH-positive afferents
arising from the SNc but also the TH-immunoreactive products
of such interneurons. Indeed, we here identified the TH-positive
cells in the human neostriatum (Figure 9). In agreement with
the previous report (Bernácer et al., 2012), our results, however,
documented that the TH cells were only scarcely distributed
in both the CN and putamen. The sparse density of the TH-
positive cells casts doubts about their contribution to the mosaic
organization of TH labeling in the human neostriatum.
Among striatal neurons, striosomal cells are unique because
they send their GABAergic inhibitory projections directly or
indirectly to the SNc, which contains dopaminergic neurons that
project back to both the striosome and matrix compartments
(Gerfen, 1984; Jiménez-Castellanos and Graybiel, 1989; Tokuno
et al., 2002; Fujiyama et al., 2011; Watabe-Uchida et al.,
2012). Accordingly, the striosome compartment could exert
global control over striatal dopamine signals by inhibiting the
activity of nigral dopaminergic cells (Crittenden and Graybiel,
2011). Considering possible mechanisms that underlie the
inhomogeneous organization of TH immunoreactivity in the
striatum of mature human brains, Graybiel et al. (1987)
suggested an involvement of presynaptic differences between
the striosome and matrix compartments in enzymatic regulation
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of dopamine content. We here showed that in the neostriatal
sections stained for TH, the striosome-to-matrix ratio of the
putamen is significantly higher (P < 0.05) than that of
the CN (Figure 8). Taken together, we suggest that there
might be a difference between the CN and putamen in
the compartment-specific homeostatic regulation of striatal
dopaminergic activities.
Given the evidence the patch (striosome) and matrix
compartments comprised about 15% and 85% of the striatal
volume, respectively, in the different species that included rat,
rhesus monkey, and human, Johnston et al. (1990) suggested
that a relatively constant ratio of 15% patch to 85% matrix
area is maintained across mammalian species including humans.
However, they also noted a slight, but significant increase
(1.7 times) in the percentage of the striatum occupied by the
striosome compartment from rat, through rhesus monkey, to
human striatum (Johnston et al., 1990). Moreover, they also
described that averaged across species, the rostral striatal sections
were slightly richer in patch compartment (17%) than the
caudal sections (9.8%) (Johnston et al., 1990). Our present
study showed that in the human neostriatal sections stained for
MEnk, the percentage of the striatum occupied by the striosome
compartment in the CN (14.0%) was significantly different
(P < 0.05) from that in both the rostral putamen (29.2%) and
caudal putamen (28.1%). This indicates that the striosome-to-
matrix ratio of the putamen was about 2.0 times that of the CN
in the human neostriatum. In view of these observations, we
posit that a species and regional difference of the small degree
in the striosome-to-matrix ratio could be found in the striatum
of mammals.
The putamen plays a critical role in the basal ganglia-
thalamocortical circuit that regulates our voluntary movements
and motor learning. Further anatomical and physiological
research on the putamen is, therefore, important for elucidating
the pathogenesis and symptomatology of human movement
disorders. The putamen also serves as the most suitable site for
the intrastriatal application of dopamine-producing transplants
in PD patients (Lindvall, 2015), as previously suggested (Kish
et al., 1988). There is a growing body of evidence that striosome-
matrix dopaminergic systems might be involved in the disease-
specific striatal pathology and symptoms of multiple human
movement disorders (Crittenden and Graybiel, 2011). Indeed,
human postmortem analyses have shown compartment-specific
pathology in the striatum of patients with movement disorders,
such as Huntington’s disease (OMIM143100; Ferrante et al.,
1987; Goto et al., 1989b; Goto and Hirano, 1990a; Morton
et al., 1993; Hedreen and Folstein, 1995; Tippett et al., 2007),
multiple system atrophy (OMIM146500) of the parkinsonian
type (Goto and Hirano, 1990b; Sato et al., 2007), and X-
linked dystonia-parkinsonism (OMIM314250; Goto et al., 2005,
2013). In this study, we performed an IHC study on FFPE
tissues from autopsied human brains, and disclosed that striatal
dopaminergic innervations labeled for TH are organized into
discrete striosome-matrix configurations in the putamen. Our
present findings provide anatomical evidence supporting the
intriguing concept that compartment-specific dysfunction of
dopamine-related neural circuits might underlie the genesis of
human movement disorders.
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